Streetbeat News

Analyst Ratings

PNW

Morgan Stanley analyst Stephen Byrd has maintained an Equal-Weight rating on Pinnacle West Capital (NYSE:PNW) and raised the price target from $73 to $75.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 1:07 pm

OGS

Morgan Stanley analyst Stephen Byrd has maintained an Equal-Weight rating on ONE Gas (NYSE:OGS) and raised the price target from $70 to $71.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 1:06 pm

MRNS

Cantor Fitzgerald analyst Charles Duncan has reiterated an Overweight rating on Marinus Pharma (NASDAQ:MRNS) and maintained a $28 price target.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 1:06 pm

NEE

Morgan Stanley analyst David Arcaro has maintained an Overweight rating on NextEra Energy (NYSE:NEE) and raised the price target from $90 to $91.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 1:05 pm

HUMA

Cantor Fitzgerald analyst Kristen Kluska has reiterated an Overweight rating on Humacyte (NASDAQ:HUMA) and maintained a $7 price target.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 1:04 pm

NSA

Morgan Stanley analyst Ronald Kamdem has maintained an Equal-Weight rating on National Storage (NYSE:NSA) but lowered the price target from $42 to $32.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 1:04 pm

FCX

Analysts have provided indifferent ratings for Freeport-McMoRan (NYSE:FCX) in the last quarter. The average price target is $42.38, implying an upside from the current price of $38.69. This average has increased by 10.08% from the previous average price target of $38.50.

Portfolio Pulse from Benzinga Insights

September 21, 2023 | 1:01 pm

NTNX

In the last quarter, Nutanix (NASDAQ:NTNX) received 2 bullish, 7 somewhat bullish, and 1 indifferent analyst ratings. The average 12-month price target for Nutanix, according to 10 analysts, is $41.6, with a high of $50.00 and a low of $35.00. This average price target has increased by 14.51% over the past month.

Portfolio Pulse from Benzinga Insights

September 21, 2023 | 1:01 pm

VCEL

Over the past 3 months, 5 analysts have published their opinion on Vericel (NASDAQ:VCEL) stock. The average price target is $41.1, implying an upside from the current price of $32.52. The average price target has increased by 5.38% over the past month. The majority of the ratings are bullish.

Portfolio Pulse from Benzinga Insights

September 21, 2023 | 1:00 pm

MESO

Analysts have provided mixed ratings for Mesoblast (NASDAQ:MESO) in the last quarter, with 2 somewhat bullish, 1 indifferent, and 1 bearish. The company has an average 12-month price target of $9.38, representing a 12.09% decrease from the previous average price target of $10.67.

Portfolio Pulse from Benzinga Insights

September 21, 2023 | 1:00 pm